PHREESIA INC (PHR) Fundamental Analysis & Valuation

NYSE:PHR • US71944F1066

Current stock price

9.15 USD
+0.78 (+9.32%)
At close:
9.15 USD
0 (0%)
After Hours:

This PHR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. PHR Profitability Analysis

1.1 Basic Checks

  • In the past year PHR was profitable.
  • In the past year PHR had a positive cash flow from operations.
  • PHR had negative earnings in 4 of the past 5 years.
  • In multiple years PHR reported negative operating cash flow during the last 5 years.
PHR Yearly Net Income VS EBIT VS OCF VS FCFPHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 50M -50M -100M -150M

1.2 Ratios

  • PHR's Return On Assets of 0.35% is fine compared to the rest of the industry. PHR outperforms 68.57% of its industry peers.
  • The Return On Equity of PHR (0.68%) is better than 68.57% of its industry peers.
Industry RankSector Rank
ROA 0.35%
ROE 0.68%
ROIC N/A
ROA(3y)-17.23%
ROA(5y)-24.63%
ROE(3y)-25.29%
ROE(5y)-33.07%
ROIC(3y)N/A
ROIC(5y)N/A
PHR Yearly ROA, ROE, ROICPHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 500 1K

1.3 Margins

  • With a decent Profit Margin value of 0.48%, PHR is doing good in the industry, outperforming 68.57% of the companies in the same industry.
  • PHR's Gross Margin of 67.93% is fine compared to the rest of the industry. PHR outperforms 65.71% of its industry peers.
  • PHR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 0.48%
GM 67.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.6%
GM growth 5Y0.96%
PHR Yearly Profit, Operating, Gross MarginsPHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. PHR Health Analysis

2.1 Basic Checks

  • PHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • PHR has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, PHR has more shares outstanding
  • The debt/assets ratio for PHR is higher compared to a year ago.
PHR Yearly Shares OutstandingPHR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
PHR Yearly Total Debt VS Total AssetsPHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M

2.2 Solvency

  • PHR has an Altman-Z score of 0.11. This is a bad value and indicates that PHR is not financially healthy and even has some risk of bankruptcy.
  • PHR has a Altman-Z score (0.11) which is in line with its industry peers.
  • The Debt to FCF ratio of PHR is 1.84, which is an excellent value as it means it would take PHR, only 1.84 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 1.84, PHR is doing good in the industry, outperforming 74.29% of the companies in the same industry.
  • PHR has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.27, PHR is doing worse than 62.86% of the companies in the same industry.
  • Although PHR's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 1.84
Altman-Z 0.11
ROIC/WACCN/A
WACC8.68%
PHR Yearly LT Debt VS Equity VS FCFPHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 1.53 indicates that PHR should not have too much problems paying its short term obligations.
  • The Current ratio of PHR (1.53) is worse than 62.86% of its industry peers.
  • PHR has a Quick Ratio of 1.53. This is a normal value and indicates that PHR is financially healthy and should not expect problems in meeting its short term obligations.
  • PHR has a worse Quick ratio (1.53) than 62.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.53
PHR Yearly Current Assets VS Current LiabilitesPHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. PHR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 105.88% over the past year.
  • Looking at the last year, PHR shows a quite strong growth in Revenue. The Revenue has grown by 14.48% in the last year.
  • The Revenue has been growing by 26.44% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)105.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.18%
Revenue 1Y (TTM)14.48%
Revenue growth 3Y19.6%
Revenue growth 5Y26.44%
Sales Q2Q%15.85%

3.2 Future

  • Based on estimates for the next years, PHR will show a very strong growth in Earnings Per Share. The EPS will grow by 305.02% on average per year.
  • Based on estimates for the next years, PHR will show a quite strong growth in Revenue. The Revenue will grow by 10.27% on average per year.
EPS Next Y984.59%
EPS Next 2Y305.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.05%
Revenue Next 2Y7.83%
Revenue Next 3Y6.94%
Revenue Next 5Y10.27%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PHR Yearly Revenue VS EstimatesPHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
PHR Yearly EPS VS EstimatesPHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

6

4. PHR Valuation Analysis

4.1 Price/Earnings Ratio

  • PHR is valuated quite expensively with a Price/Earnings ratio of 152.50.
  • PHR's Price/Earnings ratio is a bit cheaper when compared to the industry. PHR is cheaper than 62.86% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of PHR to the average of the S&P500 Index (26.21), we can say PHR is valued expensively.
  • PHR is valuated correctly with a Price/Forward Earnings ratio of 14.06.
  • Based on the Price/Forward Earnings ratio, PHR is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of PHR to the average of the S&P500 Index (23.13), we can say PHR is valued slightly cheaper.
Industry RankSector Rank
PE 152.5
Fwd PE 14.06
PHR Price Earnings VS Forward Price EarningsPHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • PHR's Enterprise Value to EBITDA is on the same level as the industry average.
  • PHR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PHR is cheaper than 85.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.14
EV/EBITDA 21.37
PHR Per share dataPHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as PHR's earnings are expected to grow with 305.02% in the coming years.
PEG (NY)0.15
PEG (5Y)N/A
EPS Next 2Y305.02%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PHR Dividend Analysis

5.1 Amount

  • No dividends for PHR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PHR Fundamentals: All Metrics, Ratios and Statistics

PHREESIA INC

NYSE:PHR (4/6/2026, 8:04:00 PM)

After market: 9.15 0 (0%)

9.15

+0.78 (+9.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-30
Earnings (Next)05-26
Inst Owners100.77%
Inst Owner Change0%
Ins Owners5.18%
Ins Owner Change6.45%
Market Cap551.65M
Revenue(TTM)480.59M
Net Income(TTM)2.31M
Analysts79.17
Price Target28.84 (215.19%)
Short Float %8.54%
Short Ratio2.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8164.58%
Min EPS beat(2)-72.5%
Max EPS beat(2)16401.7%
EPS beat(4)3
Avg EPS beat(4)4121.6%
Min EPS beat(4)-72.5%
Max EPS beat(4)16401.7%
EPS beat(8)7
Avg EPS beat(8)2072.01%
EPS beat(12)11
Avg EPS beat(12)1388.8%
EPS beat(16)15
Avg EPS beat(16)1046.77%
Revenue beat(2)0
Avg Revenue beat(2)-0.7%
Min Revenue beat(2)-0.76%
Max Revenue beat(2)-0.64%
Revenue beat(4)0
Avg Revenue beat(4)-0.48%
Min Revenue beat(4)-0.76%
Max Revenue beat(4)-0.18%
Revenue beat(8)0
Avg Revenue beat(8)-0.52%
Revenue beat(12)3
Avg Revenue beat(12)-0.04%
Revenue beat(16)7
Avg Revenue beat(16)0.38%
PT rev (1m)0.78%
PT rev (3m)-5.18%
EPS NQ rev (1m)-9.08%
EPS NQ rev (3m)32.36%
EPS NY rev (1m)0%
EPS NY rev (3m)14.94%
Revenue NQ rev (1m)-3.05%
Revenue NQ rev (3m)-1.59%
Revenue NY rev (1m)-4.35%
Revenue NY rev (3m)-3.66%
Valuation
Industry RankSector Rank
PE 152.5
Fwd PE 14.06
P/S 1.15
P/FCF 10.14
P/OCF 7
P/B 1.64
P/tB 16.66
EV/EBITDA 21.37
EPS(TTM)0.06
EY0.66%
EPS(NY)0.65
Fwd EY7.11%
FCF(TTM)0.9
FCFY9.86%
OCF(TTM)1.31
OCFY14.29%
SpS7.97
BVpS5.59
TBVpS0.55
PEG (NY)0.15
PEG (5Y)N/A
Graham Number2.75
Profitability
Industry RankSector Rank
ROA 0.35%
ROE 0.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.48%
GM 67.93%
FCFM 11.32%
ROA(3y)-17.23%
ROA(5y)-24.63%
ROE(3y)-25.29%
ROE(5y)-33.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.6%
GM growth 5Y0.96%
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 1.84
Debt/EBITDA 3.71
Cap/Depr 77.57%
Cap/Sales 5.08%
Interest Coverage N/A
Cash Conversion 317.27%
Profit Quality 2359.8%
Current Ratio 1.53
Quick Ratio 1.53
Altman-Z 0.11
F-Score5
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)83.02%
Cap/Depr(5y)99.45%
Cap/Sales(3y)5.95%
Cap/Sales(5y)8.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.18%
EPS Next Y984.59%
EPS Next 2Y305.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.48%
Revenue growth 3Y19.6%
Revenue growth 5Y26.44%
Sales Q2Q%15.85%
Revenue Next Year10.05%
Revenue Next 2Y7.83%
Revenue Next 3Y6.94%
Revenue Next 5Y10.27%
EBIT growth 1Y88.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5588.2%
EBIT Next 3Y328.44%
EBIT Next 5Y144.19%
FCF growth 1Y556.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y143.4%
OCF growth 3YN/A
OCF growth 5Y93.71%

PHREESIA INC / PHR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PHREESIA INC?

ChartMill assigns a fundamental rating of 4 / 10 to PHR.


What is the valuation status of PHREESIA INC (PHR) stock?

ChartMill assigns a valuation rating of 6 / 10 to PHREESIA INC (PHR). This can be considered as Fairly Valued.


What is the profitability of PHR stock?

PHREESIA INC (PHR) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for PHR stock?

The Price/Earnings (PE) ratio for PHREESIA INC (PHR) is 152.5 and the Price/Book (PB) ratio is 1.64.


What is the financial health of PHREESIA INC (PHR) stock?

The financial health rating of PHREESIA INC (PHR) is 4 / 10.